Literature DB >> 31274037

Frozen blastocyst embryo transfer vs. frozen cleavage-stage embryo transfer in couples with recurrent implantation failure: a cohort study.

Xiaodong Zhang1, Yang Gao1, Weiwei Liu1, Junxia Liu1, Lihong Wu1, Shun Xiong1, Jiahong Zhu1, Wei Han1, Jiang Wang1, Xiangwei Hao1, Shubiao Han1, Guoning Huang1.   

Abstract

The objective of this prospective cohort study was to investigate whether cryopreservation of cleavage or blastocyst stage embryos improves in vitro fertilization outcomes in recurrent implantation failure (RIF) patients. The study comprised 575 patients who were allocated to receive either single frozen/thawed blastocyst-stage transfer (SBT) or frozen/thawed double-cleavage-stage embryo transfer (DET). The clinical pregnancy rate, implantation rate, and ongoing pregnancy rate were higher in the SBT group compared with the DET group (41.15% vs. 27.11%, p < 0.001; 41.15% vs. 19.28%, p < 0.001; 40.03% vs. 25.9%, p < 0.001), but the miscarriage rate did not differ between the two groups. It was concluded that frozen/thawed SBT could be a preferred strategy for RIF patients.

Entities:  

Keywords:  Blastocyst transfer; cleavage-stage embryo transfer; clinical pregnancy outcomes; recurrent implantation failure

Mesh:

Year:  2019        PMID: 31274037     DOI: 10.1080/14647273.2019.1633021

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  2 in total

1.  Comparisons of benefits and risks of single embryo transfer versus double embryo transfer: a systematic review and meta-analysis.

Authors:  Shujuan Ma; Yangqin Peng; Liang Hu; Xiaojuan Wang; Yiquan Xiong; Yi Tang; Jing Tan; Fei Gong
Journal:  Reprod Biol Endocrinol       Date:  2022-01-27       Impact factor: 5.211

2.  Effect of the Re-Vitrification of Embryos at Different Stages on Embryonic Developmental Potential.

Authors:  Jingyu Li; Shun Xiong; Yanhua Zhao; Chong Li; Wei Han; Guoning Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-14       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.